The association of ERK5 expression with the metastatic spread of the disease was statistically significant in later stage breast cancer (all hazard ratios ≥1.5, p value = 0.3 for grade 1 compared with <0.02 for grades 2 and 3). This evidence concerns the gene MAPK7 and breast cancer.